The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a
Open accessAbstract
The Angelman syndrome gene, UBE3A, is subject to genomic imprinting controlled by mechanisms that are only partially understood. Its antisense transcript, UBE3A-ATS, is also imprinted and hypothesized to suppress UBE3A in cis. In this research, we showed that the mouse antisense ortholog, Ube3a-ATS, was transcribed by RNA polymerase (RNAP) II. However, unlike typical protein-coding transcripts, Ube3a-ATS was not poly-adenylated and was localized exclusively in the nucleus. It was relatively unstable with a half-life of 4 h, shorter than most protein-coding RNAs tested. To understand the role of Ube3a-ATS in vivo, a mouse model with a 0.9-kb genomic deletion over the paternal Snrpn major promoter was studied. The mice showed partial activation of paternal Ube3a, with decreased expression of Ube3a-ATS but not any imprinting defects in the Prader-Willi syndrome/Angelman syndrome region. A novel cell culture model was also generated with a transcriptional termination cassette inserted downstream of Ube3a on the paternal chromosome to reduce Ube3a-ATS transcription. In neuronally differentiated embryonic stem (ES) cells, paternal Ube3a was found to be expressed at a high level, comparable with that of the maternal allele. To further characterize the antisense RNA, a strand-specific microarray was performed. Ube3a-ATS was detectable across the entire locus of Ube3a and extended beyond the transcriptional start site of Ube3a. In summary, we conclude that Ube3a-ATS is an atypical RNAPII transcript that represses Ube3a on the paternal chromosome. These results suggest that the repression of human UBE3A-ATS may activate the expression of UBE3A from the paternal chromosome, providing a potential therapeutic strategy for patients with Angelman syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, paternal-specific deletion of multiple imprinted, paternally expressed genes on the 15q11–q13 region results in Prader–Willi syndrome, whereas maternal deletion of a single, imprinted, maternally expressed gene encoding a ubiquitin-protein ligase (UBE3A) on this same region gives rise to the Angelman syndrome phenotype.”
From Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms (2014) · cites this paper as [195]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pandey, R. R., Mondal, T., Mohammad, F., Enroth, S., Redrup, L., Komorowski, J., Nagano, T., Mancini‐DiNardo, D., & Kanduri, C. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.022 · Cited by 1,192
The non-coding Air RNA is required for silencing autosomal imprinted genes
Sleutels, F., Zwart, R., & Barlow, D. P. (2002) · Nature · doi:10.1038/415810a · Cited by 1,096
A long nuclear‐retained non‐coding RNA regulates synaptogenesis by modulating gene expression
Bernard, D., Prasanth, K. V., Tripathi, V., Colasse, S., Nakamura, T., Xuan, Z., Zhang, M. Q., Sedel, F., Jourdren, L., Coulpier, F., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.199 · Cited by 749
Differentiation of mouse embryonic stem cells into a defined neuronal lineage
Bibel, M., Richter, J., Schrenk, K., Tucker, K. L., Staiger, V., Korte, M., Goetz, M., & Barde, Y.-A. (2004) · Nature Neuroscience · doi:10.1038/nn1301 · Cited by 450
Mechanisms regulating imprinted genes in clusters
Edwards, C. A., & Ferguson‐Smith, A. C. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.04.013 · Cited by 422
Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genesPreprint
Mancini‐DiNardo, D., Steele, S. J., Levorse, J. M., Ingram, R. S., & Tilghman, S. M. (2006) · Genes & Development · doi:10.1101/gad.1416906 · Cited by 421
Dindot, S. V., Antalffy, B. A., Bhattacharjee, M. B., & Beaudet, A. L. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm288 · Cited by 418
Self-citationThe Angelman syndrome candidate gene, UBE3AIE6-AP, is imprinted in brain
Rougeulle, C., Glatt, H., & Lalande, M. (1997) · Nature Genetics · doi:10.1038/ng0997-14 · Cited by 416
Runte, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.23.2687 · Cited by 391
Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons
Huang, H.-S., Allen, J. A., Mabb, A. M., King, I. F., Miriyala, J., Taylor-Blake, B., Sciaky, N., Dutton, J. W., Lee, H.-M., Chen, X., et al. (2012) · Nature · doi:10.1038/nature10726 · Cited by 387
Distinct phenotypes distinguish the molecular classes of Angelman syndrome
Lossie, A. C., Whitney, M. M., Amidon, D., Dong, H. J., Chen, P., Theriaque, D., Hutson, A., Nicholls, R. D., Zori, R. T., Williams, C. A., et al. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.12.834 · Cited by 365
Clinical and genetic aspects of Angelman syndrome
Williams, C. A., Driscoll, D. J., & Dagli, A. I. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181def138 · Cited by 344
Prader–Willi syndrome and Angelman syndrome
Buiting, K. (2010) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30273 · Cited by 336
Speed congenics: a classic technique in the fast lane (relatively speaking)
Wakeland, E. K., Morel, L. M., Achey, K., Yui, M. A., & Longmate, J. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01126-2 · Cited by 333
Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain
Vu, T. H., & Hoffman, A. R. (1997) · Nature Genetics · doi:10.1038/ng0997-12 · Cited by 321
Mechanisms of imprinting of the Prader-Willi/Angelman region
Horsthemke, B., & Wagstaff, J. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32364 · Cited by 320
An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript
Rougeulle, C., Cardoso, C., Fontés, M., Colleaux, L., & Lalande, M. (1998) · Nature Genetics · doi:10.1038/ng0598-15 · Cited by 298
The imprinted antisense RNA at the Igf2r locus overlaps but does not imprint Mas1
Lyle, R., Watanabe, D., Vruchte, D. T., Lerchner, W., Smrzka, O. W., Wutz, A., Schageman, J. J., Hahner, L., Davies, C., & Barlow, D. P. (2000) · Nature Genetics · doi:10.1038/75546 · Cited by 288
Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a
Yamasaki, K. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg106 · Cited by 273
Jiang, Y.-H., Lev-Lehman, E., Bressler, J., Tsai, T., & Beaudet, A. L. (1999) · The American Journal of Human Genetics · doi:10.1086/302473 · Cited by 205
Self-citationChamberlain, S. J., & Brannan, C. I. (2001) · Genomics · doi:10.1006/geno.2001.6543 · Cited by 204
Redrup, L., Branco, M. R., Perdeaux, E. R., Krueger, C., Lewis, A., Santos, F., Nagano, T., Cobb, B. S., Fraser, P., & Reik, W. (2009) · Development · doi:10.1242/dev.031328 · Cited by 202
Wang, G., Kearney, D. L., Biasi, M. D., Taffet, G. E., & Cooper, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32308 · Cited by 193
Jiang, Y., Pan, Y., Zhu, L., Landa, L., Yoo, J. W., Spencer, C. M., Lorenzo, I., Brilliant, M. H., Noebels, J. L., & Beaudet, A. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012278 · Cited by 177
Self-citationAngelman syndrome (AS, MIM 105830)
Buggenhout, G. V., & Fryns, J. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.67 · Cited by 171
Seidl, C. I., Stricker, S. H., & Barlow, D. P. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601245 · Cited by 171
Tsai, T.-F., Jiang, Y.-H., Bressler, J., Armstrong, D., & Beaudet, A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1357 · Cited by 166
Self-citationA mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A
Jiang, Y., Sahoo, T., Michaelis, R. C., Bercovich, D., Bressler, J., Kashork, C. D., Liu, Q., Shaffer, L. G., Schroer, R. J., Stockton, D. W., et al. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30297 · Cited by 159
Self-citationSilencing by imprinted noncoding RNAs: is transcription the answer?
Pauler, F. M., Koerner, M. V., & Barlow, D. P. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.03.018 · Cited by 156
Meguro, M., Kashiwagi, A., Mitsuya, K., Nakao, M., Kondo, I., Saitoh, S., & Oshimura, M. (2001) · Nature Genetics · doi:10.1038/ng0501-19 · Cited by 152
Molecular epigenetics of Angelman syndrome
Lalande, M., & Calciano, M. A. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6460-0 · Cited by 149
Landers, M. A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh670 · Cited by 145
Epigenetics of imprinted long non-coding RNAs
Mohammad, F., Mondal, T., & Kanduri, C. (2009) · Epigenetics · doi:10.4161/epi.4.5.9242 · Cited by 130
Makedonski, K., Abuhatzira, L., Kaufman, Y., Razin, A., & Shemer, R. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi097 · Cited by 130
Chan, W., Costantino, N., Li, R., Lee, S. C., Su, Q., Melvin, D., Court, D. L., & Liu, P. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm163 · Cited by 127
Angelman Syndrome, a Genomic Imprinting Disorder of the Brain
Chamberlain, S. J., & Lalande, M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1728-10.2010 · Cited by 115
Bressler, J., Tsai, T., Wu, M., Tsai, S., Ramirez, M. O., Armstrong, D. L., & Beaudet, A. L. (2001) · Nature Genetics · doi:10.1038/90067 · Cited by 103
Self-citationHerzing, L. B. K., Kim, S., Cook, E. H., & Ledbetter, D. H. (2001) · The American Journal of Human Genetics · doi:10.1086/320616 · Cited by 101
Mechanisms of imprint dysregulation
Horsthemke, B. (2010) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30269 · Cited by 97
Johnstone, K. A., DuBose, A. J., Futtner, C. R., Elmore, M. D., Brannan, C. I., & Resnick, J. L. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi456 · Cited by 88
Tsix Transcription- versus RNA-Based Mechanisms in Xist Repression and Epigenetic Choice
Shibata, S., & Lee, J. T. (2004) · Current Biology · doi:10.1016/j.cub.2004.09.053 · Cited by 80
Meur, E. L., Françoise Watrin, A., Landers, M., Sturny, R., Lalande, M., & Muscatelli, F. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.07.030 · Cited by 68
Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans
Landers, M. A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki705 · Cited by 62
Control elements within the PWS/AS imprinting box and their function in the imprinting process
Kantor, B. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh085 · Cited by 53
Regulation of imprinted expression by macro non-coding RNAs
Latos, P. A., & Barlow, D. P. (2009) · RNA Biology · doi:10.4161/rna.6.2.7854 · Cited by 47
DuBose, A. J., Johnstone, K. A., Smith, E. Y., Hallett, R. A. E., & Resnick, J. L. (2009) · Neurogenetics · doi:10.1007/s10048-009-0226-9 · Cited by 42
Numata, K., Kohama, C., Abe, K., & Kiyosawa, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1201 · Cited by 32
Developmental control of imprinted expression by macro non-coding RNAs
Santoro, F., & Barlow, D. P. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.02.018 · Cited by 29
Flagged first, then by citations
Cited by
Sorted by citations
Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
Beermann, J., Piccoli, M.-T., Viereck, J., & Thum, T. (2016) · Physiological Reviews · doi:10.1152/physrev.00041.2015 · Cited by 1,740
Non-coding RNAs as drug targets
Matsui, M., & Corey, D. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.117 · Cited by 1,042
X-Inactivation, Imprinting, and Long Noncoding RNAs in Health and Disease
Lee, J. T., & Bartolomei, M. S. (2013) · Cell · doi:10.1016/j.cell.2013.02.016 · Cited by 674
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA
Meng, L., Ward, A. J., Chun, S. J., Bennett, C. F., Beaudet, A. L., & Rigo, F. (2014) · Nature · doi:10.1038/nature13975 · Cited by 537
Self-citationTopoisomerases facilitate transcription of long genes linked to autism
King, I. F. G., Yandava, C., Mabb, A. M., Hsiao, J. S., Huang, H., Pearson, B. L., Calabrese, J. M., Starmer, J., Parker, J. S., Magnuson, T., et al. (2013) · Nature · doi:10.1038/nature12504 · Cited by 430
Metadata
- Authors
- Meng, L., Person, R. E., & Beaudet, A. L.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Beaudet, Arthur L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-04-05
- Volume
- 21
- Issue
- 13
- Pages
- 3001-3012
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC3465693
- OpenAlex
- W2155623567
- Cited by
- 202
- References
- 48
- Citations by year
- 2026: 16 · 2025: 10 · 2024: 17 · 2023: 11 · 2022: 13 · 2021: 11 · 2020: 22 · 2019: 13 · 2018: 8 · 2017: 7 · 2016: 16 · 2015: 16 · 2014: 23 · 2013: 15 · 2012: 4
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Intellectual and Developmental Disabilities Research Center
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD037283)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- UBE3A, genomic imprinting, antisense RNA, RNA polymerase II, paternal gene expression, Angelman syndrome, Prader-Willi syndrome, RNA stability, transcription termination, embryonic stem cells, treatment options
- MeSH terms
- Animals, Cells, Cultured, Female, Humans, Male, Mice, Inbred C57BL, Neurons, Promoter Regions, Genetic, RNA Polymerase II, Transcription, Genetic, RNA, Antisense, Angelman Syndrome, Genomic Imprinting, Polyadenylation, Ubiquitin-Protein Ligases, Mice, Embryonic Stem Cells, snRNP Core Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
